These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 26500833)
1. Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet? Arulanandan A; Loomba R Curr Hepatol Rep; 2015 Jun; 14(2):109-118. PubMed ID: 26500833 [TBL] [Abstract][Full Text] [Related]
2. NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet? Singh SP; Barik RK J Clin Exp Hepatol; 2020; 10(1):88-98. PubMed ID: 32025168 [TBL] [Abstract][Full Text] [Related]
3. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies. Reddy YK; Marella HK; Jiang Y; Ganguli S; Snell P; Podila PSB; Maliakkal B; Satapathy SK J Clin Exp Hepatol; 2020; 10(3):245-254. PubMed ID: 32405181 [TBL] [Abstract][Full Text] [Related]
4. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. Zhou JH; Cai JJ; She ZG; Li HL World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425 [TBL] [Abstract][Full Text] [Related]
5. Natural History of Simple Steatosis or Nonalcoholic Fatty Liver. De A; Duseja A J Clin Exp Hepatol; 2020; 10(3):255-262. PubMed ID: 32405182 [TBL] [Abstract][Full Text] [Related]
6. Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet? Alkhouri N; Feldstein AE Metabolism; 2016 Aug; 65(8):1087-95. PubMed ID: 26972222 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data. Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177 [TBL] [Abstract][Full Text] [Related]
9. Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts. Mayo R; Crespo J; Martínez-Arranz I; Banales JM; Arias M; Mincholé I; Aller de la Fuente R; Jimenez-Agüero R; Alonso C; de Luis DA; Vitek L; Stritesky J; Caballería J; Romero-Gómez M; Martín-Duce A; Mugüerza Huguet JM; Busteros-Moraza JI; Idowu MO; Castro A; Martínez-Chantar ML; Ortiz P; Bruha R; Lu SC; Bedossa P; Noureddin M; Sanyal AJ; Mato JM Hepatol Commun; 2018 Jul; 2(7):807-820. PubMed ID: 30027139 [TBL] [Abstract][Full Text] [Related]
10. Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD. Pearce SG; Thosani NC; Pan JJ Biomark Res; 2013 Feb; 1(1):7. PubMed ID: 24252302 [TBL] [Abstract][Full Text] [Related]
11. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Singh S; Allen AM; Wang Z; Prokop LJ; Murad MH; Loomba R Clin Gastroenterol Hepatol; 2015 Apr; 13(4):643-54.e1-9; quiz e39-40. PubMed ID: 24768810 [TBL] [Abstract][Full Text] [Related]
13. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Castera L; Friedrich-Rust M; Loomba R Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725 [TBL] [Abstract][Full Text] [Related]
14. Liver fibrosis markers of nonalcoholic steatohepatitis. Enomoto H; Bando Y; Nakamura H; Nishiguchi S; Koga M World J Gastroenterol; 2015 Jun; 21(24):7427-35. PubMed ID: 26139988 [TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease. Imajo K; Honda Y; Yoneda M; Saito S; Nakajima A J Med Ultrason (2001); 2020 Oct; 47(4):535-548. PubMed ID: 33108553 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography. Tsai E; Lee TP Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062 [TBL] [Abstract][Full Text] [Related]
17. Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population. Arab JP; Hernández-Rocha C; Morales C; Vargas JI; Solís N; Pizarro M; Robles C; Sandoval D; Ponthus S; Benítez C; Barrera F; Soza A; Riquelme A; Arrese M Gastroenterol Hepatol; 2017; 40(6):388-394. PubMed ID: 28359548 [TBL] [Abstract][Full Text] [Related]
18. Noninvasive Diagnosis of Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis Using Machine Learning Methods: Comparative Study With Existing Quantitative Risk Scores. Wu Y; Yang X; Morris HL; Gurka MJ; Shenkman EA; Cusi K; Bril F; Donahoo WT JMIR Med Inform; 2022 Jun; 10(6):e36997. PubMed ID: 35666557 [TBL] [Abstract][Full Text] [Related]
19. Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease. Hagström H; Elfwén O; Hultcrantz R; Stål P Gastroenterol Res Pract; 2018; 2018():1942648. PubMed ID: 30057598 [TBL] [Abstract][Full Text] [Related]